UNIBIO GROUP Current Asset

The Macroaxis Fundamental Analysis lookup allows users to check a given indicator for any equity or select from a set of available indicators by clicking on the link to the right. Please note, not all equities are covered by this module due to inconsistencies in global equity categorizations. Please check also Equity Screeners to view more equity screening tools

Current Asset Analysis

Current Asset is all of company's assets that can be used to pay off current liabilities within current fiscal period or over next 12 months. Current Asset includes cash or cash equivalents, accounts receivable, short-term investments, and the portion of prepaid liabilities which will be paid within next 12 months. Because these assets are easily turned into cash, they are sometimes referred to as liquid assets.
Current Asset 
Liquid Assets 
162 M

About Current Asset

Current Asset is important to company's creditors and private equity firms as they will often be interested in how much that company has in current assets, since these assets can be easily liquidated in case the company goes bankrupt. However it is usually not enough to know if a company is in a good shape just based on current asset alone; the amount of current liabilities should always be considered.Compare to competition
In accordance with recently published financial statements UNIBIO GROUP has Current Asset of 162 M. This is 99.92% lower than that of the Consumer Goods sector, and 92.46% lower than that of Packaging and Containers industry, The Current Asset for all stocks is 99.56% higher than the company.

Peer Comparison

UNIBIO GROUP Current Asset Comparison
UNIBIO GROUP is currently under evaluation in current asset category among related companies.

Did you try this?

Run Portfolio Center Now

Portfolio Center

All portfolio managment and optimization tools to improve performance of your portfolios
Hide  View All  Next  Launch Portfolio Center
Return On Equity(11.18) %
Return On Asset(5.47) %
Profit Margin(41.21) %
Operating Margin(35.23) %
Current Valuation743.49 M
Shares Outstanding5.14 B
Price to Book1.72 times
Price to Sales6.22 times
Revenue134.56 M
Gross Profit103 M
EBITDA(27.26 M)
Net Income(55.45 M)
Cash and Equivalents91.01 M
Cash per Share0.02 times
Total Debt11.51 M
Debt to Equity0.02 times
Current Ratio3.24 times
Book Value Per Share0.10 times
Cash Flow from Operations(26.08 M)
Earnings Per Share(0.01) times
Number of Employees279
Market Capitalization821.97 M
Total Asset557 M
Retained Earnings(241 M)
Working Capital113 M
Current Asset162 M
Current Liabilities49 M
Z Score42.6